PROP1 Gene Analysis in Portuguese Patients with Combined Pituitary Hormone Deficiency

• Autor(a) principal: Lemos, MC
• Data de Publicação: 2006
• Outros Autores: Gomes, L, Bastos, M, Leite, V, Limbert, E, Carvalho, D, Bacelar, C, Monteiro, M, Fonseca, F, Agapito, A, Castro, JJ, Regateiro, F, Carvalheiro, M
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.17/2469
• topic: HCC END; Adrenocorticotropic Hormone/deficiency; Age of Onset; Codon; Cohort Studies; DNA Mutational Analysis; Genotype; Homeodomain Proteins/genetics; Hydrocortisone/deficiency; Hypopituitarism/genetics; Hypopituitarism/pathology; Magnetic Resonance Imaging; Mutation; Pedigree; Phenotype; Pituitary Gland/pathology; Pituitary Hormones/deficiency; Portugal; Prolactin/deficiency

OBJECTIVE: Mutations of the PROP1 gene lead to combined pituitary hormone deficiency (CPHD), which is characterized by a deficiency of GH, TSH, LH/FSH, PRL and, less frequently, ACTH. This study was undertaken to investigate the molecular defect in a cohort of patients with CPHD. DESIGN, PATIENTS AND MEASUREMENTS: A multicentric study involving 46 cases of CPHD (17 familial cases belonging to seven kindreds and 29 sporadic cases) selected on the basis of clinical and hormonal evidence of GH deficiency, central hypothyroidism and hypogonadotrophic hypogonadism, in the absence of an identified cause of hypopituitarism. Mutations of PROP1 were investigated by DNA sequencing. Clinical, hormonal and neuroradiological data were collected at each centre. RESULTS: PROP1 mutations were identified in all familial cases: five kindreds presented a c. 301-302delAG mutation, one kindred presented a c. 358C --> T (R120C) mutation and one presented a previously unreported initiation codon mutation, c. 2T --> C. Of the 29 sporadic cases, only two (6.9%) presented PROP1 germline mutations (c. 301-302delAG, in both). Phenotypic variability was observed among patients with the same mutations, particularly the presence and age of onset of hypocortisolism, the levels of PRL and the results of pituitary imaging. One patient presented a sellar mass that persisted into adulthood. CONCLUSIONS: This is the first report of a mutation in the initiation codon of the PROP1 gene and this further expands the spectrum of known mutations responsible for CPHD. The low mutation frequency observed in sporadic cases may be due to the involvement of other unidentified acquired or genetic causes.